Fig. 5.
AT1A receptors, but not AT1B or AT2 receptors, are involved in telmisartan neuroprotection. (A) Angiotensin II receptor gene expression after exposure to glutamate. AT1A, AT1B and AT2 gene expression were determined in rat CGCs after 24 hour exposure to glutamate. (B) CGCs were pre-treated with 1 µM telmisartan (Telm) for 2 h followed by exposure to 100 µM glutamate (Glut) for the indicated time intervals. (C) CGCs were simultaneously exposed to the NMDA receptor antagonist MK-801 (10 µM) and glutamate, and AT1A gene expression was determined 24 hours later. (D) CGCs were exposed to glutamate and AT1 receptor expression was determined by the Angiotensin II receptor binding assay, 24 and 48 hours later. (E) CGCs were treated with the AT2 receptor antagonist PD123319 (PD, 10 µM) or the AT2 receptor agonist CGP42112A (CGP, 10 µM) for one hour, followed by treatment with vehicle or telmisartan (1 µM) for two hours, followed by exposure to glutamate for 24 hours, followed by determination of LDH activity in the culture supernatant. Data are presented as means ±SEM of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 vs. Control; ##P < 0.01, ###P < 0.001 vs. Glutamate.
